ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Antibody-Mediated Rejection Can Be Assessed by Histology When DSA Is Unknown or Negative.

J. Reeve,1 P. Halloran.2

1Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada
2Department of Medicine, University of Alberta, Edmonton, AB, Canada.

Meeting: 2016 American Transplant Congress

Abstract number: C21

Keywords: Gene expression, Kidney transplantation, Rejection

Session Information

Date: Monday, June 13, 2016

Session Name: Poster Session C: Antibody Mediated Rejection: Session #1

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Halls C&D

Related Abstracts
  • DSA MFI Does Not Predict Late Antibody-Mediated Rejection Lesions Or Gene Expression Changes in Kidney Transplants
  • Validating the Microarray Test for Antibody-Mediated Rejection in a Prospective Trial: The INTERCOM Study

Diagnosis of antibody-mediated rejection (ABMR) in kidney transplants currently requires the presence of donor-specific antibody (DSA) and histologic lesions above somewhat arbitrary cutoffs. DSA is sometimes negative in otherwise ABMR-like biopsies, or is not available. Dichotomous lesion-based rules may also lose relevant information regarding the true disease state. To address these problems, we assessed the likelihood of ABMR using logistic regression. This depends less on rules and more on the overall relationship between the key variables (lesions, DSA, time post-transplant). We analyzed a set of 703 prospectively collected indication biopsies.

Probability of ABMR can be estimated either by an equation or its graphical equivalent, the nomogram. Figure 1 shows a nomogram for predicting molecular ABMR (samples called ABMR+ through microarray analysis) using the histoclinical variables that survived backward elimination.

These predictors are shown on the left of the graph. For each value of a variable, a score is read from the "Points" line, and the sum of these scores across all variables is looked up on the "Total Points" line. Finally, the corresponding probability of ABMR is read off the "Probability" line.

Figure 2 shows a nomogram for predicting biopsies diagnosed histologically (rather than molecularly) as having ABMR.

Both versions found that many DSA negative biopsies had high ABMR probabilities, as did some that didn't meet all the lesion requirements. The reverse was also true – some ABMR diagnoses had low ABMR probabilities.

We conclude that a data-driven approach to ABMR diagnosis allows a probabilistic assessment which does not rely on strict adherence to the current set of rules. These results also argue that the current requirement that ABMR must have detectable DSA is not correct.

CITATION INFORMATION: Reeve J, Halloran P. Antibody-Mediated Rejection Can Be Assessed by Histology When DSA Is Unknown or Negative. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Reeve J, Halloran P. Antibody-Mediated Rejection Can Be Assessed by Histology When DSA Is Unknown or Negative. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/antibody-mediated-rejection-can-be-assessed-by-histology-when-dsa-is-unknown-or-negative/. Accessed March 7, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Home
  • Search
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.